BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18160809)

  • 41. High plasma TIMP-1 and serum CEA levels during combination chemotherapy for metastatic colorectal cancer are significantly associated with poor outcome.
    Aldulaymi B; Byström P; Berglund A; Christensen IJ; Brünner N; Nielsen HJ; Glimelius B
    Oncology; 2010; 79(1-2):144-9. PubMed ID: 21150229
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Expression of tissue inhibitor of metalloproteinase-1 in colorectal carcinoma and its clinical implications].
    Liu Y; Jiang B; Tong HS; Lai XR
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):699-700. PubMed ID: 16762889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma or serum TIMP-1 is a predictor of survival outcomes in colorectal cancer: a meta-analysis.
    Lee JH; Choi JW; Kim YS
    J Gastrointestin Liver Dis; 2011 Sep; 20(3):287-91. PubMed ID: 21961097
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of distant metastasis and mortality in patients with stage II colorectal cancer.
    Heinzerling JH; Anthony T; Livingston EH; Huerta S
    Am Surg; 2007 Mar; 73(3):230-8. PubMed ID: 17375777
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preoperative serum vascular endothelial growth factor-a is a marker for subsequent recurrence in colorectal cancer patients.
    Alabi AA; Suppiah A; Madden LA; Monson JR; Greenman J
    Dis Colon Rectum; 2009 May; 52(5):993-9. PubMed ID: 19502868
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder.
    Staack A; Badendieck S; Schnorr D; Loening SA; Jung K
    BMC Urol; 2006 Aug; 6():19. PubMed ID: 16901349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease.
    Miele L; Forgione A; La Torre G; Vero V; Cefalo C; Racco S; Vellone VG; Vecchio FM; Gasbarrini G; Rapaccini GL; Neuman MG; Grieco A
    Transl Res; 2009 Oct; 154(4):194-201. PubMed ID: 19766963
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Invasion front-specific overexpression of tissue inhibitor of metalloproteinase-1 in liver metastases from colorectal cancer.
    Kahlert C; Bandapalli OR; Schirmacher P; Weitz J; Brand K
    Anticancer Res; 2008; 28(3A):1459-65. PubMed ID: 18630499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preoperative interleukin-6 production by mononuclear blood cells predicts survival after radical surgery for colorectal carcinoma.
    Clinchy B; Fransson A; Druvefors B; Hellsten A; Håkansson A; Gustafsson B; Sjödahl R; Håkansson L
    Cancer; 2007 May; 109(9):1742-9. PubMed ID: 17345614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma tissue inhibitor of metalloproteinases-1 as a biological marker? Pre-analytical considerations.
    Lomholt AF; Frederiksen CB; Christensen IJ; Brünner N; Nielsen HJ
    Clin Chim Acta; 2007 May; 380(1-2):128-32. PubMed ID: 17328880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors predicting survival in surgical palliative resection of stage IV colorectal cancer.
    Scabini S; Rimini E; Romairone E; Scordamaglia R; Pertile D; Ferrando V
    Minerva Chir; 2009 Jun; 64(3):303-6. PubMed ID: 19536056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
    Unsal D; Akyurek N; Uner A; Erpolat OP; Han U; Akmansu M; Mentes BB; Dursun A
    Am J Clin Oncol; 2008 Feb; 31(1):55-63. PubMed ID: 18376229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value of tissue inhibitor of matrix metalloproteinase-1 in plasma of patients with gastric cancer.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Yanoma S; Noguchi Y
    Cancer Lett; 2000 Apr; 151(1):81-6. PubMed ID: 10766426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pulmonary resection for colorectal cancer metastases: duration between cancer onset and lung metastasis as an important prognostic factor.
    Lin BR; Chang TC; Lee YC; Lee PH; Chang KJ; Liang JT
    Ann Surg Oncol; 2009 Apr; 16(4):1026-32. PubMed ID: 19184237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of plasma tissue inhibitor of metalloproteinase-1 on long-term survival in patients with gastric cancer.
    Yoshikawa T; Cho H; Tsuburaya A; Kobayashi O
    Gastric Cancer; 2009; 12(1):31-6. PubMed ID: 19390929
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of MMP-9 and TIMP-1 as prognostic markers in gastric carcinoma.
    de Mingo M; Morán A; Sánchez-Pernaute A; Iniesta P; Díez-Valladares L; Pérez-Aguirre E; de Juan C; García-Aranda C; Díaz-López A; García-Botella A; Martín-Antona E; Benito M; Torres A; Balibrea JL
    Hepatogastroenterology; 2007; 54(73):315-9. PubMed ID: 17419282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
    Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
    Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circular tumor growth: a prognostic factor in stage II colorectal carcinoma.
    Jimi S; Hotokezaka M; Eto TA; Hidaka H; Maehara N; Chijiiwa K
    Hepatogastroenterology; 2008; 55(84):926-9. PubMed ID: 18705299
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study.
    Lubos E; Schnabel R; Rupprecht HJ; Bickel C; Messow CM; Prigge S; Cambien F; Tiret L; Münzel T; Blankenberg S
    Eur Heart J; 2006 Jan; 27(2):150-6. PubMed ID: 16230310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma.
    Pennanen H; Kuittinen O; Soini Y; Turpeenniemi-Hujanen T
    Eur J Haematol; 2008 Oct; 81(4):289-97. PubMed ID: 18616513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.